® SAMPLE REPORT Case Description: Mr. J.

– Outpatient, Community Mental Health Center

Interpretive Report Mr. J. is a 44-year-old divorced man assessed at intake for services at a
community mental health center following a brief stay at a crisis stabilization unit. Mr. J. was
taken to the stabilization unit by law enforcement personnel after a serious suicide attempt
involving vehicular carbon monoxide poisoning. He had been involved in very contentious
divorce- and child custody-related proceedings for two years prior to this attempt. In addition to
having a conflictual relationship with his ex-wife, Mr. J. was estranged from his two teenage
children, and he had minimal sources of social support. His only prior contact with a mental
health professional involved a child custody evaluation conducted two years prior to the current
assessment. Mr. J.’s ex-wife was granted full custody minus planned bi-weekly visitations with
Mr. J. The worker who conducted Mr. J’s intake interview described him as depressed,
despondent, tearful, and withdrawn. He was characterized as speaking in a monotone and
giving laconic responses to questions he was asked. He was fully oriented and showed no signs
of thought disturbance. No significant history of acting out behavior was elicited. Mr. J.
acknowledged continuing suicidal ideation but denied current intent. He was diagnosed with a
Major Depressive Disorder, Severe with Melancholic Features and accepted for treatment in an
intensive outpatient program. Case descriptions do not accompany MMPI-3 reports, but are
provided here as background information. The following report was generated from Q-global™,
Pearson’s web-based scoring and reporting application, using Mr. J.’s responses to the MMPI-3.
Additional MMPI-3 sample reports, product offerings, training opportunities, and resources can
be found at PearsonAssessments.com/MMPI-3. © 2020 Pearson Education, Inc. or its affiliates.
All rights reserved. Pearson, Q-global, and Q Local are trademarks, in the US and/or other
countries, of Pearson plc. MMPI is a registered trademark of the Regents of the University of
Minnesota. CLINA24805-A EL 6/20 Interpretive Report: Clinical Settings MMPI® -3 Minnesota
Multiphasic Personality Inventory® -3 Yossef S. Ben-Porath, PhD, & Auke Tellegen, PhD ID
Number: Mr. J Age: 44 Gender: Male Marital Status: Not reported Years of Education: Not
reported Date Assessed: 08/01/2020 Copyright © 2020 by the Regents of the University of
Minnesota. All rights reserved. Distributed exclusively under license from the University of
Minnesota by NCS Pearson, Inc. Portions reproduced from the MMPI-3 test booklet. Copyright
© 2020 by the Regents of the University of Minnesota. All rights reserved. Portions excerpted
from the MMPI-3 Manual for Administration, Scoring, and Interpretation. Copyright © 2020 by
the Regents of the University of Minnesota. All rights reserved. Portions excerpted from the
MMPI-3 Technical Manual. Copyright © 2020 by the Regents of the University of Minnesota. All
rights reserved. Used by permission of the University of Minnesota Press. Minnesota
Multiphasic Personality Inventory and MMPI are registered trademarks of the University of
Minnesota. Pearson is a trademark in the U.S. and/or other countries of Pearson Education, Inc.,
or its affiliate(s). This report contains copyrighted material and trade secrets. Qualified licensees
may excerpt portions of this output report, limited to the minimum text necessary to accurately
describe their significant core conclusions, for incorporation into a written evaluation of the
examinee, in accordance with their profession's citation standards, if any. No adaptations,
translations, modifications, or special versions may be made of this report without prior written
permission from the University of Minnesota Press. [ 1.0 / RE1 / QG1 ] MMPI-3 Validity Scales
20 100 90 80 70 60 50 40 30 VRIN TRIN F Fp Fs FBS L K Raw Score: Response %: CRIN VRIN TRIN
Combined Response Inconsistency Variable Response Inconsistency True Response
Inconsistency 1 39 F Fp Fs FBS RBS Infrequent Responses Infrequent Psychopathology
Responses Infrequent Somatic Responses Symptom Validity Scale Response Bias Scale 1 47 1 50
8 66 14 54 9 51 0 36 8 58 120 110 Cannot Say (Raw): 13 T Score: T T --- --- --- --- --- --- --- --- --- ---
--- --- --- --- --- --- --- --- --- L K Uncommon Virtues Adjustment Validity RBS 2 38 The highest and
lowest T scores possible on each scale are indicated by a "---"; MMPI-3 T scores are non-
gendered. CRIN 2 39 93 93 94 89 100 100 97 96 93 100 MMPI® -3 Interpretive Report: Clinical
Settings ID: Mr. J 08/01/2020, Page 2 MMPI-3 Higher-Order (H-O) and Restructured Clinical (RC)
Scales 20 100 90 80 70 60 50 40 30 EID THD BXD RCd RC1 RC2 RC4 RC6 RC7 RC8 RC9 Raw Score:
T Score: Response %: EID THD BXD Emotional/Internalizing Dysfunction Thought Dysfunction
Behavioral/Externalizing Dysfunction 34 80 95 RCd RC1 RC2 RC4 Demoralization Somatic
Complaints Low Positive Emotions Antisocial Behavior RC6 RC7 RC8 RC9 Ideas of Persecution
Dysfunctional Negative Emotions Aberrant Experiences Hypomanic Activation 2 46 100 17 80
100 4 44 100 2 49 100 10 75 93 6 55 100 1 50 93 1 44 100 10 55 100 1 36 100 120 110 Higher-
Order Restructured Clinical --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- The
highest and lowest T scores possible on each scale are indicated by a "---"; MMPI-3 T scores are
non-gendered. MMPI® -3 Interpretive Report: Clinical Settings ID: Mr. J 08/01/2020, Page 3
MMPI-3 Somatic/Cognitive Dysfunction and Internalizing Scales 20 100 90 80 70 60 50 40 30
NUC EAT COG HLP SFD NFC STR WRY CMP ARX ANP BRF Raw Score: T Score: Response %: MLS
NUC EAT COG Malaise Neurological Complaints Eating Concerns Cognitive Complaints 5 59 100
WRY CMP ARX ANP BRF Worry Compulsivity Anxiety-Related Experiences Anger Proneness
Behavior-Restricting Fears SUI HLP SFD NFC STR Suicidal/Death Ideation
Helplessness/Hopelessness Self-Doubt Inefficacy Stress 3 100 1 46 100 0 44 100 0 38 100 7 86
100 9 77 100 7 78 100 5 68 100 3 49 6 65 100 7 59 100 2 63 100 3 51 92 Somatic/Cognitive
Internalizing 120 110 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
--- --- MLS 88 72 SUI The highest and lowest T scores possible on each scale are indicated by a
"---"; MMPI-3 T scores are non-gendered. MMPI® -3 Interpretive Report: Clinical Settings ID: Mr.
J 08/01/2020, Page 4 MMPI-3 Externalizing and Interpersonal Scales 20 100 90 80 70 60 50 40
30 JCP SUB IMP ACT AGG CYN SFI DOM DSF SAV SHY Raw Score: T Score: Response %: ACT AGG
CYN Activation Aggression Cynicism 5 59 FML JCP SUB IMP Family Problems Juvenile Conduct
Problems Substance Abuse Impulsivity SFI DOM DSF SAV SHY Self-Importance Dominance
Disaffiliativeness Social Avoidance Shyness 1 41 1 45 4 58 1 48 1 49 1 37 9 55 1 34 5 55 4 58
Externalizing Interpersonal 120 110 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
--- --- --- The highest and lowest T scores possible on each scale are indicated by a "---"; MMPI-3
T scores are non-gendered. FML 6 69 80 100 100 100 100 100 100 100 89 57 78 100 MMPI® -3
Interpretive Report: Clinical Settings ID: Mr. J 08/01/2020, Page 5 MMPI-3 PSY-5 Scales 20 100
90 80 70 60 50 40 30 AGGR PSYC DISC NEGE INTR Raw Score: T Score: Response %: AGGR PSYC
DISC NEGE INTR Aggressiveness Psychoticism Disconstraint Negative Emotionality/Neuroticism
Introversion/Low Positive Emotionality 1 31 93 8 60 12 68 93 5 50 100 1 47 100 120 110 --- --- ---
--- --- --- --- --- --- --- 86 The highest and lowest T scores possible on each scale are indicated by a
"---"; MMPI-3 T scores are non-gendered. MMPI® -3 Interpretive Report: Clinical Settings ID: Mr.
J 08/01/2020, Page 6 MMPI-3 T SCORES (BY DOMAIN) PROTOCOL VALIDITY SUBSTANTIVE
SCALES *The test taker provided scorable responses to less than 90% of the items scored on this
scale. See the relevant profile page for the specific percentage. Scale scores shown in bold font
are interpreted in the report. Note. This information is provided to facilitate interpretation
following the recommended structure for MMPI-3 interpretation in Chapter 5 of the MMPI-3
Manual for Administration, Scoring, and Interpretation, which provides details in the text and an
outline in Table 5-1. Content Non-Responsiveness 13 39 39 54 T CNS CRIN VRIN TRIN Over-
Reporting 66* 50 47 51 58 F Fp Fs FBS RBS Under-Reporting 36 38 L K Somatic/Cognitive
Dysfunction 46 59 38 44 46 RC1 MLS NUC EAT COG Emotional Dysfunction 80 80 72 86 78 77
EID RCd SUI HLP SFD NFC 75 60* RC2 INTR 55 68 65 49* 59 51 63 68 RC7 STR WRY CMP ARX
ANP BRF NEGE Thought Dysfunction 49 50 THD RC6 44 RC8 47 PSYC Behavioral Dysfunction 44
55 59* 48 58 BXD RC4 FML JCP SUB 36 45 41 49 55 RC9 IMP ACT AGG CYN 50 DISC Interpersonal
Functioning 37 34* 31 58* 55* 69 SFI DOM AGGR DSF SAV SHY MMPI® -3 Interpretive Report:
Clinical Settings ID: Mr. J 08/01/2020, Page 7 SYNOPSIS Scores on the MMPI-3 Validity Scales
raise concerns about the possible impact of unscorable responses on the validity of this
protocol. With that caution noted, scores on the Substantive Scales indicate emotional,
behavioral, and interpersonal dysfunction. Emotional-internalizing findings include suicidal
ideation, demoralization, lack of positive emotions, helplessness and hopelessness, self-doubt,
perceived inefficacy, negative emotionality, stress, and worry. Behavioral-externalizing problems
relate to lack of energy and engagement. Interpersonal difficulties include lack of self-esteem
and social anxiety. PROTOCOL VALIDITY Content Non-Responsiveness Unscorable Responses The
test taker answered less than 90% of the items on the following scales. The resulting scores may
therefore be artificially lowered. In particular, the absence of elevation on these scales is not
interpretable1 . A list of all items for which the test taker provided unscorable responses
appears under the heading "Item-Level Information." Infrequent Responses (F): 89%
Compulsivity (CMP): 88% Family Problems (FML): 80% Dominance (DOM): 89% Disaffiliativeness
(DSF): 57% Social Avoidance (SAV): 78% Introversion/Low Positive Emotionality (INTR): 86%
Inconsistent Responding The test taker responded to the items in a consistent manner,
indicating that he responded relevantly. Over-Reporting The test taker may have over-reported
general psychological dysfunction. The extent of possible over-reporting cannot be precisely
determined because of 4 unscorable responses on the 35-item Infrequent Responses (F) scale.
The following table shows what the T scores for F would be if the unscorable items had been
answered in the keyed direction. This interpretive report is intended for use by a professional
qualified to interpret the MMPI-3. The information it contains should be considered in the
context of the test taker's background, the circumstances of the assessment, and other available
information. The report includes extensive annotation, which appears as superscripts following
each statement in the narrative, keyed to Endnotes with accompanying Research References,
which appear in the final two sections of the report. Additional information about the
annotation features is provided in the headnotes to these sections and in the MMPI-3 User's
Guide for the Score and Clinical Interpretive Reports. MMPI® -3 Interpretive Report: Clinical
Settings ID: Mr. J 08/01/2020, Page 8 See Chapter 5 of the MMPI-3 Manual for Administration,
Scoring, and Interpretation for guidance on interpreting elevated scores on F. Under-Reporting
There are no indications of under-reporting in this protocol. SUBSTANTIVE SCALE
INTERPRETATION Clinical symptoms, personality characteristics, and behavioral tendencies of
the test taker are described in this section and organized according to an empirically guided
framework. (Please see Chapter 5 of the MMPI-3 Manual for Administration, Scoring, and
Interpretation for details.) Statements containing the word "reports" are based on the item
content of MMPI-3 scales, whereas statements that include the word "likely" are based on
empirical correlates of scale scores. Specific sources for each statement can be viewed with the
annotation features of this report. The following interpretation needs to be considered in light
of cautions noted about the possible impact of unscorable responses on the validity of this
protocol. Somatic/Cognitive Dysfunction There are no indications of somatic or cognitive
dysfunction in this protocol. Emotional Dysfunction The test taker reports a history of
suicidal/death ideation and/or past suicide attempts2 . He likely is at risk for self-harm3 , is
preoccupied with suicide and death4 , and is at risk for current suicidal ideation and attempts5 .
His responses indicate considerable emotional distress that is likely to be perceived as a crisis6 .
More specifically, he reports experiencing significant demoralization, feeling overwhelmed, and
being extremely unhappy, sad, and dissatisfied with his life7 . He very likely complains about
significant depression8 and experiences sadness and despair9 . In particular, he reports having
lost hope and believing he cannot change and overcome his problems and is incapable of
reaching his life goals10. He very likely feels hopeless, overwhelmed, and that life is a strain11,
believes he cannot be helped11 and gets a raw deal from life12, and lacks motivation for
change13. He also reports lacking confidence, feeling worthless, and believing he is a burden to
others14. He very likely experiences self-doubt, feels insecure and inferior, and is self-
disparaging and intropunitive15. In addition, he reports being very indecisive and inefficacious,
believing he is incapable of making decisions and dealing effectively with crisis situations, and
even having difficulties dealing with small, inconsequential matters16. He very likely
experiences subjective incompetence and shame17 and lacks perseverance and self-reliance18 .
The test taker reports a lack of positive emotional experiences and a lack of interest19. He likely
is pessimistic20 and presents with anhedonia21 . He reports experiencing an elevated level of
negative emotionality22 and indeed likely experiences various negative emotions23. More
specifically, he reports an above average level of stress24. He likely complains about Scale: F T
score based on scorable responses: 66 Cutoff for over-reporting concern: 75 If answered in the
keyed direction The T score would be 1 69 2 72 3 75 4 78 MMPI® -3 Interpretive Report: Clinical
Settings ID: Mr. J 08/01/2020, Page 9 stress25 and feels incapable of controlling his anxiety
level25. He also reports excessive worry, including worries about misfortune and finances, as
well as preoccupation with disappointments26. He indeed likely worries excessively27 and
ruminates28 . Thought Dysfunction There are no indications of disordered thinking in this
protocol. Behavioral Dysfunction There are no indications of maladaptive externalizing behavior
in this protocol. The test taker reports a low energy level29 and indeed likely has a low energy
level30 and is disengaged from his normal activities30 . Interpersonal Functioning Scales The
test taker describes himself as lacking in positive qualities31 . He reports being shy, easily
embarrassed, and uncomfortable around others32. He is likely to be socially introverted33 and
inhibited34, anxious and nervous in social situations35, and viewed by others as socially
awkward36 . DIAGNOSTIC CONSIDERATIONS This section provides recommendations for
psychodiagnostic assessment based on the test taker's MMPI-3 results. It is recommended that
he be evaluated for the following, bearing in mind possible threats to protocol validity noted
earlier in this report: Emotional-Internalizing Disorders - Major depression and other
anhedonia-related disorders37 - Features of personality disorders involving negative
emotionality such as Dependent38 - Generalized anxiety disorder25 - Disorders involving
excessive worry39 Interpersonal Disorders - Social anxiety disorder (social phobia)40
TREATMENT CONSIDERATIONS This section provides inferential treatment-related
recommendations based on the test taker's MMPI-3 scores. The following recommendations
need to be considered in light of cautions noted earlier about possible threats to protocol
validity. Areas for Further Evaluation - Risk for suicide should be assessed immediately41 . -
Need for antidepressant medication42 . Psychotherapy Process Issues - Serious emotional
difficulties may motivate him for treatment43 . - Indecisiveness may interfere with establishing
treatment goals and progress in treatment44 . MMPI® -3 Interpretive Report: Clinical Settings
ID: Mr. J 08/01/2020, Page 10 Possible Targets for Treatment - Demoralization as an initial
target45 - Loss of hope and feelings of despair as early targets for intervention46 - Low self-
esteem and other manifestations of self-doubt47 - Anhedonia48 - Developing stress
management skills49 - Excessive worry and rumination39 - Anxiety in social situations40 ITEM-
LEVEL INFORMATION Unscorable Responses Following is a list of items to which the test taker
did not provide scorable responses. Unanswered or double answered (both True and False)
items are unscorable. The scale(s) on which the items appear are in parentheses following the
item content. 37. Item content omitted. (CRIN, VRIN, SAV, INTR) 52. Item content omitted.
(CMP) 67. Item content omitted. (CRIN, TRIN, F, DSF) 145. Item content omitted. (CRIN, TRIN, F,
FML) 175. Item content omitted. (CRIN, VRIN, DSF) 193. Item content omitted. (FBS) 197. Item
content omitted. (DOM, AGGR) 222. Item content omitted. (EID, RC2, SAV, INTR) 268. Item
content omitted. (RBS, L) 280. Item content omitted. (F, FML) 291. Item content omitted. (CRIN,
VRIN, DSF) 293. Item content omitted. (CRIN, VRIN, EID, ANP, NEGE) 310. Item content omitted.
(F, RC6) Critical Responses Seven MMPI-3 scales—Suicidal/Death Ideation (SUI),
Helplessness/Hopelessness (HLP), Anxiety-Related Experiences (ARX), Ideas of Persecution
(RC6), Aberrant Experiences (RC8), Substance Abuse (SUB), and Aggression (AGG)—have been
designated by the test authors as having critical item content that may require immediate
attention and follow-up. Items answered by the individual in the keyed direction (True or False)
on a critical scale are listed below if his T score on that scale is 65 or higher. However, any item
answered in the keyed direction on SUI is listed. The percentage of the MMPI-3 normative
sample that answered each item in the keyed direction is provided in parentheses following the
item content. Suicidal/Death Ideation (SUI, T Score = 72) 38. Item content omitted. (True, 22.2%)
93. Item content omitted. (True, 8.1%) 120. Item content omitted. (True, 2.5%) 118. Item
content omitted. (True, 10.9%) 169. Item content omitted. (True, 8.7%) 214. Item content
omitted. (True, 12.3%) 224. Item content omitted. (True, 4.6%) 238. Item content omitted. (True,
45.4%) MMPI® -3 Interpretive Report: Clinical Settings ID: Mr. J 08/01/2020, Page 11
Helplessness/Hopelessness (HLP, T Score = 86) 282. Item content omitted. (False, 22.0%) 296.
Item content omitted. (True, 8.4%) User-Designated Item-Level Information The following item-
level information is based on the report user's selection of additional scales, and/or of lower
cutoffs for the critical scales from the previous section. Items answered by the test taker in the
keyed direction (True or False) on a selected scale are listed below if his T score on that scale is
at the user-designated cutoff score or higher. The percentage of the MMPI-3 normative sample
that answered each item in the keyed direction is provided in parentheses following the item
content. Demoralization (RCd, T Score = 80) 17. Item content omitted. (True, 11.3%) 22. Item
content omitted. (True, 44.5%) 30. Item content omitted. (True, 14.9%) 48. Item content
omitted. (True, 29.4%) 89. Item content omitted. (True, 41.0%) 105. Item content omitted.
(False, 15.7%) 144. Item content omitted. (True, 35.3%) 152. Item content omitted. (True,
23.9%) 158. Item content omitted. (True, 21.9%) 172. Item content omitted. (True, 21.5%) 187.
Item content omitted. (True, 58.0%) 204. Item content omitted. (True, 27.8%) 217. Item content
omitted. (False, 46.0%) 229. Item content omitted. (True, 28.7%) 260. Item content omitted.
(True, 25.7%) 288. Item content omitted. (True, 32.0%) 331. Item content omitted. (True, 22.0%)
Low Positive Emotions (RC2, T Score = 75) 1. Item content omitted. (False, 17.9%) 20. Item
content omitted. (False, 27.2%) 47. Item content omitted. (False, 41.2%) 62. Item content
omitted. (False, 29.7%) 78. Item content omitted. (True, 13.2%) 83. Item content omitted. (False,
7.3%) 246. Item content omitted. (False, 9.1%) 282. Item content omitted. (False, 22.0%) 302.
Item content omitted. (False, 33.5%) 323. Item content omitted. (False, 27.0%) Self-Doubt (SFD,
T Score = 78) 17. Item content omitted. (True, 11.3%) 48. Item content omitted. (True, 29.4%)
89. Item content omitted. (True, 41.0%) 184. Item content omitted. (True, 11.8%) 229. Item
content omitted. (True, 28.7%) 249. Item content omitted. (True, 14.6%) 288. Item content
omitted. (True, 32.0%) MMPI® -3 Interpretive Report: Clinical Settings ID: Mr. J 08/01/2020,
Page 12 Inefficacy (NFC, T Score = 77) 27. Item content omitted. (True, 37.7%) 68. Item content
omitted. (True, 45.2%) 108. Item content omitted. (True, 42.3%) 144. Item content omitted.
(True, 35.3%) 152. Item content omitted. (True, 23.9%) 198. Item content omitted. (True, 25.2%)
274. Item content omitted. (True, 29.0%) 299. Item content omitted. (True, 20.9%) 324. Item
content omitted. (True, 40.2%) Stress (STR, T Score = 68) 8. Item content omitted. (False, 31.7%)
73. Item content omitted. (False, 26.7%) 112. Item content omitted. (True, 30.9%) 128. Item
content omitted. (True, 31.6%) 234. Item content omitted. (False, 58.8%) Worry (WRY, T Score =
65) 29. Item content omitted. (True, 42.5%) 98. Item content omitted. (True, 26.3%) 123. Item
content omitted. (True, 40.6%) 286. Item content omitted. (True, 54.0%) 309. Item content
omitted. (True, 57.8%) 335. Item content omitted. (True, 50.9%) Shyness (SHY, T Score = 69) 44.
Item content omitted. (True, 27.8%) 90. Item content omitted. (True, 29.1%) 114. Item content
omitted. (True, 38.0%) 177. Item content omitted. (True, 38.6%) 225. Item content omitted.
(True, 52.2%) 295. Item content omitted. (False, 32.3%) Negative Emotionality/Neuroticism
(NEGE, T Score = 68) 26. Item content omitted. (True, 31.2%) 73. Item content omitted. (False,
26.7%) 75. Item content omitted. (True, 16.9%) 98. Item content omitted. (True, 26.3%) 115.
Item content omitted. (True, 38.4%) 123. Item content omitted. (True, 40.6%) 206. Item content
omitted. (True, 46.0%) 228. Item content omitted. (True, 26.0%) 252. Item content omitted.
(True, 35.8%) 263. Item content omitted. (True, 59.1%) 286. Item content omitted. (True, 54.0%)
335. Item content omitted. (True, 50.9%) MMPI ® -3 Interpretive Report: Clinical Settings ID: Mr.
J 08/01/2020, Page 13 ENDNOTES This section lists for each statement in the report the MMPI-3
score(s) that triggered it. In addition, each statement is identified as a Test Response, if based
on item content, a Correlate, if based on empirical correlates, or an Inference, if based on the
report authors' judgment. (This information can also be accessed on-screen by placing the
cursor on a given statement.) For correlate-based statements, research references (Ref. No.) are
provided, keyed to the consecutively numbered reference list following the endnotes. 1
Correlate: Response % < 90, Ref. 12 2 Test Response: SUI=72 3 Correlate: SUI=72, Ref. 7, 26, 31 4
Correlate: SUI=72, Ref. 4, 7, 20, 21, 30, 31, 32, 42, 45 5 Correlate: SUI=72, Ref. 4, 7, 20, 21, 31,
42, 43, 45 6 Correlate: EID=80, Ref. 7, 25, 33, 45 7 Test Response: RCd=80 8 Correlate: RCd=80,
Ref. 1, 5, 7, 8, 9, 10, 13, 14, 16, 17, 18, 23, 24, 29, 30, 34, 36, 37, 38, 40, 41, 44, 45, 46, 47, 49,
50; RC2=75, Ref. 1, 5, 7, 8, 9, 10, 16, 17, 18, 23, 24, 34, 36, 37, 38, 40, 41, 45, 46, 47, 49, 50 9
Correlate: RCd=80, Ref. 7 10 Test Response: HLP=86 11 Correlate: HLP=86, Ref. 45 12 Correlate:
RCd=80, Ref. 45; HLP=86, Ref. 45 13 Correlate: HLP=86, Ref. 7 14 Test Response: SFD=78 15
Correlate: SFD=78, Ref. 7, 45 16 Test Response: NFC=77 17 Correlate: NFC=77, Ref. 7 18
Correlate: NFC=77, Ref. 10 19 Test Response: RC2=75 20 Correlate: RC2=75, Ref. 15, 40, 45;
HLP=86, Ref. 45 21 Correlate: RC2=75, Ref. 7, 45 22 Test Response: NEGE=68 23 Correlate:
NEGE=68, Ref. 7 24 Test Response: STR=68 25 Correlate: STR=68, Ref. 7 26 Test Response:
WRY=65 27 Correlate: WRY=65, Ref. 7 28 Correlate: WRY=65, Ref. 7; SFD=78, Ref. 7, 45 29 Test
Response: RC9=36 30 Correlate: RC9=36, Ref. 7, 45 31 Test Response: SFI=37 32 Test Response:
SHY=69 33 Correlate: SHY=69, Ref. 1, 2, 6, 7, 11 34 Correlate: SHY=69, Ref. 1, 6, 7, 45 35
Correlate: SHY=69, Ref. 6, 7, 10, 19, 30 36 Correlate: SHY=69, Ref. 7, 45 37 Correlate: RCd=80,
Ref. 7, 22, 27, 28, 35, 41, 45, 48; RC2=75, Ref. 7, 22, 27, 28, 35, 41, 45, 48 38 Correlate:
NEGE=68, Ref. 3, 7, 39 39 Inference: WRY=65 40 Inference: SHY=69 41 Inference: SUI=72 42
Correlate: RC2=75, Ref. 7 43 Inference: EID=80; RCd=80; NEGE=68 44 Inference: NFC=77 45
Inference: RCd=80 MMPI® -3 Interpretive Report: Clinical Settings ID: Mr. J 08/01/2020, Page 14
46 Inference: HLP=86 47 Inference: SFD=78 48 Inference: RC2=75 49 Inference: STR=68 MMPI ®
-3 Interpretive Report: Clinical Settings ID: Mr. J 08/01/2020, Page 15 RESEARCH REFERENCE LIST
The following studies are sources for empirical correlates identified in the Endnotes section of
this report. 1. Anderson, J. L., Sellbom, M., Ayearst, L., Quilty, L. C., Chmielewski, M., & Bagby, R.
M. (2015). Associations between DSM-5 Section III personality traits and the Minnesota
Multiphasic Personality Inventory 2-Restructured Form (MMPI-2-RF) scales in a psychiatric
patient sample. Psychological Assessment, 27(3), 801–815.
https://doi.org/10.1037/pas0000096 2. Anderson, J. L., Sellbom, M., Pymont, C., Smid, W., De
Saeger, H., & Kamphuis, J. H. (2015). Measurement of DSM-5 Section II personality disorder
constructs using the MMPI-2-RF in clinical and forensic samples. Psychological Assessment,
27(3), 786–800. https://doi.org/10.1037/pas0000103 3. Anderson, J. L., Wood, M. E.,
Tarescavage, A. M., Burchett, D., & Glassmire, D. M. (2018). The role of dimensional personality
psychopathology in a forensic inpatient psychiatric setting. Journal of Personality Disorders,
32(4), 447–464. https://doi.org/10.1521/pedi_2017_31_301 4. Anestis, J. C., Finn, J. A.,
Gottfried, E. D., Hames, J. L., Bodell, L. P., Hagan, C. R., Arnau, R. C., Anestis, M. D., Arbisi, P. A., &
Joiner, T. E. (2018). Burdonesomeness, belongingness, and capability: Assessing the
interpersonal-psychological theory of suicide with MMPI-2-RF scales. Assessment, 25(4), 415–
431. https://doi.org/10.1177/1073191116652227 5. Arbisi, P. A., Sellbom, M., & Ben-Porath, Y.
S. (2008). Empirical correlates of the MMPI-2 Restructured Clinical (RC) Scales in psychiatric
inpatients. Journal of Personality Assessment, 90(2), 122–128.
https://doi.org/10.1080/00223890701845146 6. Ayearst, L. E., Sellbom, M., Trobst, K. K., &
Bagby, R. M. (2013). Evaluating the interpersonal content of the MMPI-2-RF Interpersonal
Scales. Journal of Personality Assessment, 95(2), 187–196.
https://doi.org/10.1080/00223891.2012.730085 7. Ben-Porath, Y. S., & Tellegen, A. (2020). The
Minnesota Multiphasic Personality Inventory-3 (MMPI-3): Technical manual. University of
Minnesota Press. 8. Binford, A., & Liljequist, L. (2008). Behavioral correlates of selected MMPI-2
Clinical, Content, and Restructured Clinical scales. Journal of Personality Assessment, 90(6),
608–614. https://doi.org/10.1080/00223890802388657 9. Block, A. R., Ben-Porath, Y. S., &
Marek, R. J. (2013). Psychological risk factors for poor outcome of spine surgery and spinal cord
stimulator implant: A review of the literature and their assessment with the MMPI-2-RF. The
Clinical Neuropsychologist, 27(1), 81–107. https://doi.org/10.1080/13854046.2012.721007 10.
Burchett, D. L., & Ben-Porath, Y. S. (2010). The impact of over-reporting on MMPI-2-RF
substantive scale score validity. Assessment, 17(4), 497–516.
https://doi.org/10.1177/1073191110378972 11. Crighton, A. H., Tarescavage, A. M., Gervais, R.
O., & Ben-Porath, Y. S. (2017). The generalizability of over-reporting across self-report measures:
An investigation with the Minnesota Multiphasic Personality Inventory-2-Restructured Form and
the Personality Assessment Inventory in a civil disability sample. Assessment, 24(5), 555–574.
https://doi.org/10.1177/1073191115621791 12. Dragon, W. R., Ben-Porath, Y. S., & Handel, R.
W. (2012). Examining the impact of unscorable item responses on the validity and
interpretability of MMPI-2/MMPI-2-RF Restructured Clinical (RC) Scale scores. Assessment,
19(1), 101–113. https://doi.org/10.1177/1073191111415362 13. Erbes, C. R., Polusny, M. A.,
Arbisi, P. A., & Koffel, E. (2012). PTSD symptoms in a cohort of National Guard Soldiers deployed
to Iraq: Evidence for nonspecific and specific components. Journal of Affective Disorders, 142(1–
3), 269–274. https://doi.org/10.1016/j.jad.2012.05.013 MMPI® -3 Interpretive Report: Clinical
Settings ID: Mr. J 08/01/2020, Page 16 14. Finn, J. A., Ben-Porath, Y. S., & Tellegen, A. (2015).
Dichotomous versus polytomous response options in psychopathology assessment: Method or
meaningful variance? Psychological Assessment, 27(1), 184–193.
https://doi.org/10.1037/pas0000044 15. Forbey, J. D., & Ben-Porath, Y. S. (2007). A comparison
of the MMPI-2 Restructured Clinical (RC) and Clinical Scales in a substance abuse treatment
sample. Psychological Services, 4(1), 46–58. https://doi.org/10.1037/1541-1559.4.1.46 16.
Forbey, J. D., & Ben-Porath, Y. S. (2008). Empirical correlates of the MMPI-2 Restructured Clinical
(RC) Scales in a non-clinical setting. Journal of Personality Assessment, 90(2), 136–141.
https://doi.org/10.1080/00223890701845161 17. Forbey, J. D., Ben-Porath, Y. S., & Arbisi, P. A.
(2012). The MMPI-2 computer adaptive version (MMPI-2-CA) in a Veterans Administration
medical outpatient facility. Psychological Assessment, 24(3), 628–639.
https://doi.org/10.1037/a0026509 18. Forbey, J. D., Ben-Porath, Y. S., & Gartland, D. (2009).
Validation of the MMPI-2 Computerized Adaptive version (MMPI-2-CA) in a correctional intake
facility. Psychological Services, 6(4), 279–292. https://doi.org/10.1037/a0016195 19. Forbey, J.
D., Lee, T. T. C., & Handel, R. W. (2010). Correlates of the MMPI-2-RF in a college setting.
Psychological Assessment, 22(4), 737–744. https://doi.org/10.1037/a0020645 20. Glassmire, D.
M, Tarescavage, A. M., Burchett, D., Martinez, J., & Gomez, A. (2016). Clinical utility of the
MMPI-2-RF SUI items and scale in a forensic inpatient setting: Association with interview self-
reports and future suicidal behavior. Psychological Assessment, 28(11), 1502–1509.
https://doi.org/10.1037/pas0000220 21. Gottfried, E., Bodell, L., Carbonell, J., & Joiner, T.
(2014). The clinical utility of the MMPI-2-RF Suicidal/Death Ideation Scale. Psychological
Assessment, 26(4), 1205–1211. https://doi.org/10.1037/pas0000017 22. Haber, J. C., & Baum, L.
J. (2014). Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF) Scales
as predictors of psychiatric diagnoses. South African Journal of Psychology, 44(4), 439–453.
https://doi.org/10.1177/0081246314532788 23. Handel, R. W., & Archer, R. P. (2008). An
investigation of the psychometric properties of the MMPI-2 Restructured Clinical (RC) Scales
with mental health inpatients. Journal of Personality Assessment, 90(3), 239–249.
https://doi.org/10.1080/00223890701884954 24. Kamphuis, J. H., Arbisi, P. A., Ben-Porath, Y. S.,
& McNulty, J. L. (2008). Detecting comorbid Axis-II status among inpatients using the MMPI-2
Restructured Clinical Scales. European Journal of Psychological Assessment, 24, 157–164.
https://doi.org/10.1027/1015-5759.24.3.157 25. Lanyon, R. I., & Thomas, M. L. (2013).
Assessment of global psychiatric categories: The PSI/PSI-2 and the MMPI-2-RF. Psychological
Assessment, 25(1), 227–232. https://doi.org/10.1037/a0030313 26. Laurinaityte, I.,
Laurinavicius, A., Ustinaviciute, L., Wygant, D. B., Sellbom, M. (2017). Utility of the MMPI-2
Restructured Form (MMPI-2-RF) in a sample of Lithuanian male offenders. Law and Human
Behavior, 41(5), 494–505. https://doi.org/10.1037/lhb0000254 27. Lee, T. T. C., Graham, J. R., &
Arbisi, P. A. (2018). The utility of MMPI-2-RF scale scores in the differential diagnosis of
schizophrenia and major depressive disorder. Journal of Personality Assessment, 100(3), 305–
312. https://doi.org/10.1080/00223891.2017.1300906 MMPI® -3 Interpretive Report: Clinical
Settings ID: Mr. J 08/01/2020, Page 17 28. McCord, D. M., & Drerup, L. C. (2011). Relative
practical utility of the Minnesota Multiphasic Personality Inventory-2 Restructured Clinical
Scales versus the Clinical Scales in a chronic pain patient sample. Journal of Clinical and
Experimental Neuropsychology, 33(1), 140–146.
https://doi.org/10.1080/13803395.2010.495056 29. McDevitt-Murphy, M. E., Weathers, F. W.,
Flood, A. M., Eakin, D. E., & Benson, T. A. (2007). The utility of the PAI and the MMPI-2 for
discriminating PTSD, depression, and social phobia in trauma-exposed college students.
Assessment, 14(2), 181–195. https://doi.org/10.1177/1073191106295914 30. Menton, W. H.,
Crighton, A. H., Tarescavage, A. M., Marek, R. J., Hicks, A. D., & Ben-Porath, Y. S. (2019).
Equivalence of laptop and tablet administrations of the Minnesota Multiphasic Personality
Inventory-2 Restructured Form. Assessment, 26(4), 661–669.
https://doi.org/10.1177/1073191117714558 31. Miller, S. N., Bozzay, M. L., Ben-Porath, Y. S., &
Arbisi, P. A. (2019). Distinguishing levels of suicide risk in depressed male veterans: The role of
internalizing and externalizing psychopathology as measured by the MMPI-2-RF. Assessment,
26(1), 85–98. https://doi.org/10.1177/1073191117743787 32. Rogers, M. L., Anestis, J. C.,
Harrop, T. M., Schneider, M., Bender, T. W., Ringer, F. B., & Joiner, T. E. (2017). Examination of
MMPI-2-RF substantive scales as indicators of acute suicidal affective disturbance components.
Journal of Personality Assessment, 99(4), 424–434.
https://doi.org/10.1080/00223891.2016.1222393 33. Romero, I. E., Toorabally, N., Burchett, D.,
Tarescavage, A. M., & Glassmire, D. M. (2017). Mapping the MMPI-2-RF substantive scales onto,
internalizing, externalizing, and thought dysfunction dimensions in a forensic inpatient setting.
Journal of Personality Assessment, 99(4), 351–362.
https://doi.org/10.1080/00223891.2016.1223681 34. Sellbom, M., Anderson, J. L., & Bagby, R.
M. (2013). Assessing DSM-5 Section III personality traits and disorders with the MMPI-2-RF.
Assessment, 20(6), 709–722. https://doi.org/10.1177/1073191113508808 35. Sellbom, M.,
Bagby, R. M., Kushner, S., Quilty, L. C., & Ayearst, L. E. (2011). Diagnostic construct validity of the
MMPI-2 Restructured Form (MMPI-2-RF) scale scores. Assessment, 19(2), 176–186.
https://doi.org/10.1177/1073191111428763 36. Sellbom, M., Ben-Porath, Y. S., & Bagby, R. M.
(2008). On the hierarchical structure of mood and anxiety disorders: Confirmatory evidence and
elaboration of a model of temperament markers. Journal of Abnormal Psychology, 117(3), 576–
590. https://doi.org/10.1037/a0012536 37. Sellbom, M., Ben-Porath, Y. S., & Graham, J. R.
(2006). Correlates of the MMPI-2 Restructured Clinical (RC) Scales in a college counseling
setting. Journal of Personality Assessment, 86(1), 89–99.
https://doi.org/10.1207/s15327752jpa8601_10 38. Sellbom, M., Graham, J. R., & Schenk, P. W.
(2006). Incremental validity of the MMPI-2 Restructured Clinical (RC) Scales in a private practice
sample. Journal of Personality Assessment, 86(2), 196–205.
https://doi.org/10.1207/s15327752jpa8602_09 39. Sellbom, M., & Smith, A. (2017).
Assessment of DSM-5 Section II personality disorders with the MMPI-2-RF in a nonclinical
sample. Journal of Personality Assessment, 99(4), 384–397.
https://doi.org/10.1080/00223891.2016.1242074 40. Shkalim, E. (2015). Psychometric
evaluation of the MMPI-2/MMPI-2-RF Restructured Clinical Scales in an Israeli sample.
Assessment, 22(4), 607–618. https://doi.org/10.1177/1073191114555884 41. Simms, L. J.,
Casillas, A., Clark, L. A., Watson, D., & Doebbeling, B. N. (2005). Psychometric evaluation of the
Restructured Clinical Scales of the MMPI-2. Psychological Assessment, 17(3), 345–358.
https://doi.org/10.1037/1040-3590.17.3.345 MMPI® -3 Interpretive Report: Clinical Settings ID:
Mr. J 08/01/2020, Page 18 End of Report 42. Stanley, I. H., Yancey, J. R., Patrick, C. J., & Joiner, T.
E. (2018). A distinct configuration of MMPI-2-RF scales RCd and RC9/ACT is associated with
suicide attempt risk among suicide ideators in a psychiatric outpatient sample. Psychological
Assessment, 30(9), 1249–1254. https://doi.org/10.1037/pas0000588 43. Tarescavage, A. M.,
Glassmire, D. M., & Burchett, D. (2018). Minnesota Multiphasic Personality Inventory-2-
Restructured Form markers of future suicidal behavior in a forensic psychiatric hospital.
Psychological Assessment, 30(2), 170–178. https://doi.org/10.1037/pas0000463 44.
Tarescavage, A. M., Scheman, J., & Ben-Porath, Y. S. (2015). Reliability and validity of the
Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) in evaluations
of chronic low back pain patients. Psychological Assessment, 27(2), 433–446.
https://doi.org/10.1037/pas0000056 45. Tellegen, A., & Ben-Porath, Y. S. (2008/2011).
Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF): Technical
manual. University of Minnesota Press. 46. Tellegen, A., Ben-Porath, Y. S., Sellbom, M., Arbisi, P.
A., McNulty, J. L., & Graham, J. R. (2006). Further evidence on the validity of the MMPI-2
Restructured Clinical (RC) Scales: Addressing questions raised by Rogers, Sewell, Harrison, and
Jordan and Nichols. Journal of Personality Assessment, 87,(2), 148–171.
https://doi.org/10.1207/s15327752jpa8702_04 47. Vachon, D. D., Sellbom, M., Ryder, A. G.,
Miller, J. D., & Bagby, R. M. (2009). A five-factor model description of depressive personality
disorder. Journal of Personality Disorders, 23(5), 447–465.
https://doi.org/10.1521/pedi.2009.23.5.447 48. Van der Heijden, P. T., Egger, J. I. M., Rossi, G.
M. P., Grundel, G., & Derksen, J. J. L. (2013). The MMPI-2-Restructured Form and the standard
MMPI-2 Clinical Scales in relation to DSM-IV. European Journal of Psychological Assessment,
29(3), 182–188. https://doi.org/10.1027/1015-5759/a000140 49. Wolf, E. J., Miller, M. W.,
Orazem, R. J., Weierich, M. R., Castillo, D. T., Milford, J., Kaloupek, D. G., & Keane, T. M. (2008).
The MMPI-2 Restructured Clinical Scales in the assessment of posttraumatic stress disorder and
comorbid disorders. Psychological Assessment, 20(4), 327–340.
https://doi.org/10.1037/a0012948 50. Wygant, D. B., Boutacoff, L. I., Arbisi, P. A., Ben-Porath, Y.
S., Kelly, P. H., & Rupp, W. M. (2007). Examination of the MMPI-2 Restructured Clinical (RC)
Scales in a sample of bariatric surgery candidates. Journal of Clinical Psychology in Medical
Settings, 14(3), 197–205. https://doi.org/10.1007/s10880-007-9073-8 MMPI® -3 Interpretive
Report: Clinical Settings ID: Mr. J 08/01/2020, Page 19 ITEM RESPONSES 331. 1 332. 2 333. 1
334. 1 335. 1 1. 2 2. 1 3. 2 4. 2 5. 1 6. 2 7. 2 8. 2 9. 2 10. 1 11. 2 12. 2 13. 2 14. 1 15. 2 16. 1 17. 1
18. 2 19. 2 20. 2 21. 1 22. 1 23. 1 24. 1 25. 2 26. 1 27. 1 28. 2 29. 1 30. 1 31. 2 32. 1 33. 2 34. 2
35. 2 36. 2 37. / 38. 1 39. 2 40. 1 41. 2 42. 1 43. 2 44. 1 45. 1 46. 2 47. 2 48. 1 49. 1 50. 1 51. 2 52.
/ 53. 2 54. 1 55. 2 56. 1 57. 2 58. 1 59. 1 60. 2 61. 1 62. 2 63. 1 64. 1 65. 1 66. 2 67. / 68. 1 69. 1
70. 2 71. 2 72. 1 73. 2 74. 2 75. 1 76. 2 77. 2 78. 1 79. 2 80. 1 81. 2 82. 2 83. 2 84. 2 85. 1 86. 1
87. 1 88. 1 89. 1 90. 1 91. 2 92. 2 93. 1 94. 2 95. 1 96. 2 97. 1 98. 1 99. 1 100. 2 101. 2 102. 1 103.
2 104. 1 105. 2 106. 2 107. 1 108. 1 109. 2 110. 2 111. 2 112. 1 113. 1 114. 1 115. 1 116. 2 117. 1
118. 1 119. 2 120. 1 121. 1 122. 2 123. 1 124. 2 125. 1 126. 2 127. 1 128. 1 129. 2 130. 2 131. 2
132. 1 133. 2 134. 1 135. 2 136. 2 137. 2 138. 1 139. 2 140. 1 141. 1 142. 2 143. 2 144. 1 145. /
146. 2 147. 2 148. 2 149. 2 150. 2 151. 1 152. 1 153. 2 154. 1 155. 2 156. 1 157. 1 158. 1 159. 2
160. 2 161. 2 162. 1 163. 2 164. 2 165. 2 166. 2 167. 2 168. 2 169. 1 170. 2 171. 1 172. 1 173. 2
174. 2 175. / 176. 2 177. 1 178. 2 179. 2 180. 2 181. 2 182. 2 183. 1 184. 1 185. 2 186. 1 187. 1
188. 2 189. 2 190. 2 191. 2 192. 1 193. / 194. 2 195. 1 196. 1 197. / 198. 1 199. 1 200. 2 201. 1
202. 2 203. 2 204. 1 205. 2 206. 1 207. 2 208. 2 209. 2 210. 1 211. 2 212. 2 213. 1 214. 1 215. 1
216. 2 217. 2 218. 2 219. 2 220. 2 221. 1 222. / 223. 2 224. 1 225. 1 226. 1 227. 1 228. 1 229. 1
230. 2 231. 2 232. 2 233. 2 234. 2 235. 1 236. 2 237. 1 238. 1 239. 2 240. 2 241. 2 242. 2 243. 1
244. 2 245. 2 246. 2 247. 1 248. 2 249. 1 250. 2 251. 2 252. 1 253. 2 254. 2 255. 2 256. 1 257. 2
258. 2 259. 2 260. 1 261. 2 262. 2 263. 1 264. 2 265. 1 266. 2 267. 2 268. / 269. 2 270. 2 271. 2
272. 1 273. 2 274. 1 275. 2 276. 2 277. 2 278. 1 279. 2 280. / 281. 2 282. 2 283. 1 284. 2 285. 2
286. 1 287. 2 288. 1 289. 2 290. 2 291. / 292. 2 293. / 294. 2 295. 2 296. 1 297. 1 298. 1 299. 1
300. 1 301. 2 302. 2 303. 1 304. 1 305. 2 306. 2 307. 1 308. 2 309. 1 310. / 311. 2 312. 2 313. 1
314. 2 315. 1 316. 2 317. 2 318. 1 319. 2 320. 2 321. 2 322. 1 323. 2 324. 1 325. 1 326. 2 327. 2
328. 1 329. 2 330. 2 MMPI® -3 Interpretive Report: Clinical Settings ID: Mr. J 08/01/2020, Page
20